CN
Shenzhen Health SwifTech
AccuGen™ meta Solutions
Unlock the Power of Precision with Metagenomic (mNGS) Pathogen Detection Service
  • There is no need for pre-separation and culture of pathogens. By directly sequencing the nucleic acids in the sample, it is possible to quickly and comprehensively identify a variety of microorganisms present in the sample (including viruses, bacteria, fungi and parasites) .
  • AccuGen™ meta Solutions is particularly suitable for the diagnosis of infectious diseases, especially when the pathogen is unclear or difficult to culture.It plays a significant role in diagnosing critical and complicated cases.
  • In addition, AccuGen™ meta Solutions can also discover unknown pathogens and help predict diseases, including cancer, infectious diseases, and genetic disorders.
  • AccuGen™ meta Solutions focuses more on the entire genome of a microbial community or ecosystem, conducting high-throughput sequencing of all nucleic acids in the specimen.
Coverage of 26,653 pathogens
AccuGen™
Comprehensive and rapid detection of all pathogenic microorganisms in a sample
  • No culture required

    Solve the problem of identification of microorganisms that cannot be cultured at present

  • High positive

    More than twice that of traditional culture methods

  • Quick identification

    Report out in 24h

  • High specificity

    Accurate identification to species level

Targeting the Essentials: Core Pathogens
Applicable scenarios

AccuGen™ meta Solutions can conduct unbiased detection of microbial nucleic acids in the specimen in one go, which has significant clinical application value in improving the diagnosis and treatment capabilities of medical institutions for rare and difficult infectious diseases, and promoting the rational use of antibiotics.

  • Bloodstream Infection

  • Focal Infection

  • Central Nervous System Infection

  • Respiratory System Infection

Scope of application

  • Fever of Unknown Origin (FUO)

  • Severe pneumonia，Fulminant meningitis，Sepsis，etc.

  • Organ transplant recipients，Cancer patients，Immunocompromised populations，etc.

Indication for detection
Detection Process
Suitable for illumina & MGl Sequencing platform.
AccuGen™ Sample Submission Requirements.
Sample Type Sample Size Collection Tube Requirements Transportation Conditions
Alveolar lavage fluid ≥2 ml Sterile threaded tube Delivery under refrigeration: 48 hours delivery to laboratary;
on dry ice Transportation: > 48 hours delivery to laboratory.
Sputum ≥2 ml Sterile threaded tube
Cerebrospinal fluid ≥2 ml Sterile threaded tube
Nasopharyngeal swab ≥2 swabs Sterile threaded tube
Blood ≥2 ml cfDNA blood collection tube Normal temperature transportation
Blood (infant) ≥2 ml cfDNA blood collection tube
Cerebrospinal fluid (infant) ≥1 ml Sterile threaded tube Delivery under refrigeration: 48 hours delivery to laboratary;
on dry ice Transportation: > 48 hours delivery to laboratory.
Urine ≥2 ml Sterile threaded tube
Tissues ≥3 mm³ Sterile threaded tube
Hydrothorax and ascites ≥2 ml Sterile threaded tube
Abscess aspiration ≥2 ml Sterile threaded tube
Wound exudate ≥2 swabs Sterile threaded tube
Bile ≥2 ml Sterile threaded tube
Joint effusion ≥2 ml Sterile threaded tube
Aqueous humor ≥0.1 ml Sterile threaded tube
Other puncture fluids ≥1 ml Sterile threaded tube
Bone marrow ≥2 ml cfDNA blood collection tube Normal temperature transportation
Pathological section ≥5 sections Section box